Submissions from 2021
The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window, Rupesh Kotecha
Immediate Dental Implant Placement in the Oncologic Setting: A Conceptual Framework, Evan Rosen
Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases, Rupesh Kotecha and Manmeet Ahluwalia
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma, Riccardo Lencioni
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia
Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT), Rupesh Kotecha
Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations, Rupesh Kotecha and Muni Rubens
Case report of visual biofeedback-driven, magnetic resonance-guided single-fraction SABR in breath hold for early stage non-small-cell lung cancer, Michael Chuong, Rupesh Kotecha, Minesh Mehta, Sonia Adamson, Tino Romaguera, Matthew Hall, Diane Alvarez, Alonso Gutierrez, Vivek Mishra, Fernando De Zarraga, and Kathryn Mittauer
Daily online adaptive magnetic resonance image (MRI) guided stereotactic body radiation therapy for primary renal cell cancer, Tugce Kutuk, James McCulloch, Kathryn Mittauer, Tino Romaguera, Diane Alvarez, Alonso Gutierrez, Michael Chuong, and Rupesh Kotecha
Ocular outcomes after treatment of cytomegalovirus (CMV) retinitis using adoptive immunotherapy with CMV-specific cytotoxic T-lymphocytes, Guenther Koehne
Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy, Claudia Martin Diaz, Eduardo Guizan Corrales, Star Belnap, Jonathan Kline, Radhan Gopalani, Sylvia Marrero, and Felipe De Los Rios La Rosa
PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series, Alexander Mohler, Belkys Salinas, Nicholas Lambrou, Karissa Nazur, Yazmin Odia, and Rupesh Kotecha
Contemporary Neuroscience Core Curriculum for Medical Schools, Yazmin Odia
Characterization of response to atezolizumab + bevacizumab versus sorafenib for hepatocellular carcinoma: Results from the IMbrave150 trial, Riccardo Lencioni
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study, John Paul Diaz and Eric Schroeder
PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series, Alexander Mohler, Belkys Salinas, Rupesh Kotecha, Karissa Nazur, Yazmin Odia, and Nicholas Lambrou
Blood pressure reduction and outcome after endovascular therapy: a secondary analysis of the BEST study, Amy Starosciak and Felipe De Los Rios La Rosa
Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial, John Paul Diaz, Troy Gatcliffe, Zuanel Diaz, Eric Schroeder, Nicholas Lambrou, Nicole Eiseler, and Thomas Morrissey
Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis, Ana Sandoval Leon
Maximum intravenous alteplase dose for obese stroke patients is not associated with greater likelihood of worse outcomes, Star Belnap, Anshul Saxena, Emir Veledar, Amy Starosciak, and Felipe De Los Rios La Rosa
Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change, Felipe De Los Rios La Rosa and Amy Starosciak
The Evolving Personalized Landscape of Colorectal Cancer Therapies, Michael Chuong